China PharmaHub to Distribute Liver Cancer Treatment

China PharmaHub Corp. signed an exclusive agreement allowing the company to distribute radioactive glass spheres to treat liver cancer. The agreement covers China and several other countries in Southeast Asia. PharmaHub said the technology is similar to one approved by the FDA in the US, presumably TheraSphere. More details.... Stock Symbol: (OTCBB: WRLC)